Petra Nederlof
7PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 22, 2025
Tamoxifen induces PI3K activation in uterine cancer.Kirsten Kübler, Agostina Nardone, Shankara Anand
|Sep 09, 2023
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.Sonja Vliek, Florentine S Hilbers, Erik van Werkhoven
|May 06, 2022
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.Marlous Hoogstraat, Esther H Lips, Isabel Mayayo-Peralta
|Feb 06, 2022
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.Leonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu
|Oct 01, 2021
Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial.Philip C Schouten, Lisa Richters, Daniel J Vis
|Aug 24, 2019
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients.Richard D Baird, Annelot G J van Rossum, Mafalda Oliveira
Pageof 2
Frequent Collaborators
3 joint publications
Agnes Jager
2 joint publications
Erik van Werkhoven
2 joint publications
Jelle Wesseling
2 joint publications
Esther H Lips
2 joint publications
Sabine C Linn
1 joint publications
Anieta M Sieuwerts
1 joint publications
Job van Riet
1 joint publications
Dik C van Gent
1 joint publications
Corinna Ernst
1 joint publications
Alexander Burges
